Parkinson’s Disease Related Content

New Possibilities for Parkinson’s Disease

A team of investigators from McLean Hospital and Massachusetts General Hospital (MGH) reported that reprogramming a patient’s own skin cells to replace cells in the brain that are progressively lost during Parkinson’s disease (PD) is technically feasible. PD is the second most common...

Personalizing Stem Cell Therapy for Parkinson’s Disease

In the United States alone, as many as one million people have Parkinson’s disease (PD), with approximately 60,000 cases being diagnosed each year, according to the Parkinson’s Disease Foundation. Kwang-Soo Kim, PhD , director of the Molecular Neurobiology Laboratory at McLean Hospital and professor...

Staff Profile: Kwang-Soo Kim, PhD

Kwang-Soo Kim, PhD, has over 25 years of experience investigating molecular and developmental neurobiology of the midbrain dopamine neuronal system in health and disease, focusing on elucidating the transcriptional mechanisms underlying development and maintenance of dopamine neurons. Based on basic...

Staff Profile: Pierre R. Leblanc, PhD

Pierre R. Leblanc, PhD, received his BSc in Biochemistry from McGill University and his PhD in Biochemistry from McMaster University, studying membranes biogenesis. He performed his post-doctoral work at the Massachusetts Institute of Technology, focusing on the gamma/delta T-cell receptor...

Staff Profile: Kai-Christian Sonntag, MD, PhD

As a graduate of University of Heidelberg Medical School, Dr. Sonntag studied the molecular biology of viruses, and as a research fellow at the Transplantation Biology Research Center at Massachusetts General Hospital, he conducted research in transplantation immunology. In 2000, he joined McLean...

Staff Profile: Anna W. Sromek, PhD

Anna W. Sromek, PhD, received her BS in chemistry at the University of Chicago in 1996, and PhD in organic chemistry at the University of Illinois at Chicago in 2005. She was a NIDA post-doctoral research fellow at McLean Hospital from 2008 to 2010, and a recipient of the Alfred Pope Award for Young...

Staff Profile: Ole Isacson, Dr Med Sci

Dr. Ole Isacson is a professor of neurology at Harvard Medical School and founding director of the Neuroregeneration Research Institute at McLean Hospital. His work is focused on the understanding and treatments of neurodegenerative disease, with particular emphasis on distinguishing critical...

Staff Profile: Penny Hallett, PhD

Penny Hallett, PhD, is an associate professor of psychiatry at Harvard Medical School and co-director of the Neuroregeneration Research Institute (NRI). She received her PhD from the University of Manchester, UK, and completed post-doctoral studies at Massachusetts General Hospital, moving in 2006...